Cargando…
Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation
BACKGROUND: Plecanatide, with the exception of a single amino acid replacement, is identical to human uroguanylin and is approved in the United States for adults with chronic idiopathic constipation (CIC). This double-blind, placebo-controlled, phase III study evaluated the efficacy and safety of pl...
Autores principales: | DeMicco, Michael, Barrow, Laura, Hickey, Bernadette, Shailubhai, Kunwar, Griffin, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673020/ https://www.ncbi.nlm.nih.gov/pubmed/29147135 http://dx.doi.org/10.1177/1756283X17734697 |
Ejemplares similares
-
A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
por: Miner Jr, Philip B, et al.
Publicado: (2017) -
Clinical utility of plecanatide in the treatment of chronic idiopathic constipation
por: Islam, Bianca N, et al.
Publicado: (2018) -
Plecanatide: a new guanylate cyclase agonist for the treatment of chronic idiopathic constipation
por: Rao, Satish S.C.
Publicado: (2018) -
Profile of plecanatide in the treatment of chronic idiopathic constipation: design, development, and place in therapy
por: Sharma, Amol, et al.
Publicado: (2019) -
Therapeutically targeting guanylate cyclase‐C: computational modeling of plecanatide, a uroguanylin analog
por: Brancale, Andrea, et al.
Publicado: (2017)